VentiRx, the developers of motolimod, a TLR8 agonist, have published preclinical and clinical results that indicate effective immune system stimulatio...
A new paper from Peter Schafer, et al, of Celgene shows how biomarkers can be used to monitor treatment response in an inflammatory disease setting. T...
Researchers sought to explore biomarkers in pre- and on- treatment mCRC patients receiving chemotherapy with and without cediranib, in order to identi...
This month's paper features the results of a Phase I study on a new cancer immunotherapy drug. VTX-2337 is a toll-like receptor 8 agonist, activating...
This article from GEN suggests tackling cancer's heterogeneity using a multipronged approach that includes current advancements in the detection of pr...
If you were unable to attend the webinar or would like to view the webinar again, a recorded version is now available for your convenience. View Recor...
Research published in the British Journal of Cancer correlates membranous expression of PODXL in urothelial bladder cancer with unfavorable tumor char...